(Q35684466)

9 August 2017

title

Metronomic Cyclophosphamide and Methotrexate Chemotherapy Combined with 1E10 Anti-Idiotype Vaccine in Metastatic Breast Cancer (English)

1 reference

9 August 2017

1 reference

metastatic breast cancer

1 reference

1 reference

Jorge L Soriano

1

1 reference

9 August 2017

Noyde Batista

2

1 reference

9 August 2017

Eduardo Santiesteban

3

1 reference

9 August 2017

Mayté Lima

4

1 reference

9 August 2017

Joaquín González

5

1 reference

9 August 2017

Robin García

6

1 reference

9 August 2017

Yohanka Zarza

7

1 reference

9 August 2017

María V López

8

1 reference

9 August 2017

Myriam Rodríguez

9

1 reference

9 August 2017

Jorge L Loys

10

1 reference

9 August 2017

Narciso Montejo

11

1 reference

9 August 2017

Frank Aguirre

12

1 reference

9 August 2017

Amparo Macías

13

1 reference

9 August 2017

Ana M Vázquez

14

1 reference

9 August 2017

publication date

14 July 2011

1 reference

International Journal of Breast Cancer

9 August 2017

published in

1 reference

9 August 2017

volume

2011

1 reference

9 August 2017

page(s)

710292

1 reference

Creative Commons Attribution 3.0 Unported

9 August 2017

copyright license

start time

1 January 2011

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Cellular and humoral immune response to N-Glycolyl-GM3 elicited by prolonged immunotherapy with an anti-idiotypic vaccine in high-risk and metastatic breast cancer patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3262579

Low-dose metronomic daily cyclophosphamide and weekly tirapazamine: a well-tolerated combination regimen with enhanced efficacy that exploits tumor hypoxia.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3262579

Angiogenesis of breast cancer

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3262579

A comparative analysis of low-dose metronomic cyclophosphamide reveals absent or low-grade toxicity on tissues highly sensitive to the toxic effects of maximum tolerated dose regimens

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3262579

The anti-angiogenic basis of metronomic chemotherapy

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3262579

Possible mechanisms of acquired resistance to anti-angiogenic drugs: implications for the use of combination therapy approaches.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3262579

Less is more, regularly: metronomic dosing of cytotoxic drugs can target tumor angiogenesis in mice

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3262579

Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3262579

Interferon-alpha-mediated down-regulation of angiogenesis-related genes and therapy of bladder cancer are dependent on optimization of biological dose and schedule.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3262579

Syngeneic anti-idiotypic monoclonal antibodies to an anti-NeuGc-containing ganglioside monoclonal antibody

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3262579

New perspectives in clinical oncology from angiogenesis research

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3262579

Minimizing long-term tumor burden: the logic for metronomic chemotherapeutic dosing and its antiangiogenic basis.

27 July 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F710292

Thrombospondin-1 associated with tumor microenvironment contributes to low-dose cyclophosphamide-mediated endothelial cell apoptosis and tumor growth suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F710292

An anti-idiotype vaccine elicits a specific response to N-glycolyl sialic acid residues of glycoconjugates in melanoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F710292

Combined therapeutic effect of a monoclonal anti-idiotype tumor vaccine against NeuGc-containing gangliosides with chemotherapy in a breast carcinoma model

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F710292

Efficacy and mechanisms of action of rmB7.2-Ig as an antitumor agent in combination with Adriamycin and Cytoxan chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F710292

Doxorubicin and paclitaxel enhance the antitumor efficacy of vaccines directed against HER 2/neu in a murine mammary carcinoma model

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F710292

Metronomic cyclophosphamide regimen selectively depletes CD4+CD25+ regulatory T cells and restores T and NK effector functions in end stage cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F710292

Immune responses in breast cancer patients immunized with an anti-idiotype antibody mimicking NeuGc-containing gangliosides

21 January 2018

1 reference

12 December 2020

Breast cancer: metastatic

1 reference

12 December 2020

Prolonged clinical benefit with metronomic chemotherapy in patients with metastatic breast cancer

1 reference

12 December 2020

Antitumor properties of an anti-idiotypic monoclonal antibody in relation to N-glycolyl-containing gangliosides

1 reference

12 December 2020

Results and long term follow-up for 1581 patients with metastatic breast carcinoma treated with standard dose doxorubicin-containing chemotherapy: a reference

1 reference

12 December 2020

Evaluating strategies to enhance the anti-tumor immune response to a carbohydrate mimetic peptide vaccine

1 reference

12 December 2020

Generation of a murine monoclonal antibody specific for N-glycolylneuraminic acid-containing gangliosides that also recognizes sulfated glycolipids

1 reference

12 December 2020

Active immunotherapy with 1E10 anti-idiotype vaccine in patients with small cell lung cancer: report of a phase I trial

1 reference

12 December 2020

Immunotherapy and chemotherapy--a practical partnership

1 reference

12 December 2020

Identifiers

DOI

10.4061/2011/710292

1 reference

9 August 2017

1 reference

9 August 2017

1 reference